72 related articles for article (PubMed ID: 2538759)
21. Regions of the EBV genome involved in latency and lymphocyte immortalization.
Miller G
Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408
[No Abstract] [Full Text] [Related]
22. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist.
Ng SB; Khoury JD
Adv Anat Pathol; 2009 Jan; 16(1):40-55. PubMed ID: 19098466
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo studies with Epstein-Barr virus (EBV). A review.
Dunkel VC
Ann Clin Lab Sci; 1973; 3(6):424-8. PubMed ID: 4356929
[No Abstract] [Full Text] [Related]
24. Cell transformation induced by Epstein-Barr virus--living dangerously.
Rowe M
Semin Cancer Biol; 2001 Dec; 11(6):403-5. PubMed ID: 11669601
[No Abstract] [Full Text] [Related]
25. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
Bachmann AE; Giraudo Conesa LC; Braun M
Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
[No Abstract] [Full Text] [Related]
26. Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma.
Nilsson K; Klein G
Adv Cancer Res; 1982; 37():319-80. PubMed ID: 6305160
[No Abstract] [Full Text] [Related]
27. Epstein-Barr virus as the cause of a human cancer.
Epstein MA
Nature; 1978 Aug; 274(5673):740. PubMed ID: 210391
[No Abstract] [Full Text] [Related]
28. Identification of the target cells in human B lymphocytes for transformation by Epstein-Barr virus.
Katsuki T; Hinuma Y; Yamamoto N; Abo T; Kumagai K
Virology; 1977 Dec; 83(2):287-94. PubMed ID: 201086
[No Abstract] [Full Text] [Related]
29. On the biology of Epstein-Barr virus persistence: a reappraisal.
Rickinson AB
Adv Exp Med Biol; 1990; 278():137-46. PubMed ID: 1963030
[No Abstract] [Full Text] [Related]
30. Epstein-Barr virus strategy in normal and neoplastic B cells.
Klein G
Cell; 1994 Jun; 77(6):791-3. PubMed ID: 8004668
[No Abstract] [Full Text] [Related]
31. The Epstein-Barr virus.
S Afr Med J; 1980 Mar; 57(11):385-6. PubMed ID: 6250229
[No Abstract] [Full Text] [Related]
32. Infections due to Epstein-Barr virus during pregnancy.
Icart J; Didier J
J Infect Dis; 1981 Mar; 143(3):499. PubMed ID: 6262414
[No Abstract] [Full Text] [Related]
33. X-linked immunocompetence and Epstein-Barr virus oncogenesis.
Hecht F
Lancet; 1979 Apr; 1(8121):881. PubMed ID: 86133
[No Abstract] [Full Text] [Related]
34. Special issue in memory of Denis Parsons Burkitt.
Br J Haematol; 2012 Mar; 156(6):689-783. PubMed ID: 22548220
[No Abstract] [Full Text] [Related]
35. Tribute to Denis Burkitt.
Nelson CL; Temple NJ
J Med Biogr; 1994 Aug; 2(3):180-3. PubMed ID: 11639942
[No Abstract] [Full Text] [Related]
36. Felicity.
Can Med Assoc J; 1970 Dec; 103(13):1345. PubMed ID: 20311737
[No Abstract] [Full Text] [Related]
37. Epstein-Barr virus. Chance and felicity.
Galloway J
Nature; 1989 Apr; 338(6215):463-4. PubMed ID: 2538759
[No Abstract] [Full Text] [Related]
38. Burkitt lymphoma and the discovery of Epstein-Barr virus.
Epstein A
Br J Haematol; 2012 Mar; 156(6):777-9. PubMed ID: 22233499
[TBL] [Abstract][Full Text] [Related]
39. [Biology of the Epstein-Barr virus].
Morand P; Seigneurin JM
Ann Biol Clin (Paris); 1989; 47(7):421-7. PubMed ID: 2554764
[TBL] [Abstract][Full Text] [Related]
40. New oncologic associations for the Epstein-Barr virus.
Gartner JG; Seemayer TA
Am J Surg Pathol; 1982 Jul; 6(5):471-3. PubMed ID: 6289684
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
